Isto Biologics Expands Global Reach with $60 Million NovaBone Acquisition

Hopkinton, Tuesday, 4 August 2026.
On August 4, 2026, Isto Biologics acquired Florida-based NovaBone from Halma plc for $60 million. Backed by private equity firm Keensight Capital, the deal broadens Isto’s synthetic bone graft portfolio.